Condition: Coronary Artery Disease Progression · Sponsor: Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
This study evaluates whether plaques in young patients with familial hypercholesterolemia (aged below 50 years) are susceptible to significant plaque regression with early, intensive lipid lowering therapy.
This description comes directly from the study's public registry record.
Erik SG Stroes, MD, PhD · +205669111 · e.s.stroes@amsterdamumc.nl
Always discuss trial participation with your own doctor first.
| Amsterdam UMC, location AMC | Amsterdam, North Holland, Netherlands | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05783804